Abbreviation title: Rev Diabet Stud
Frequency: Quarterly
ISSN print edition: 1613-6071
ISSN online edition: 1614-0575
Editor: Massimo Trucco, M.D.
Hon. Editor: Anders A. Sima, M.D., Ph.D.

Year Impact Factor (2-yr)* Impact Factor (3-yr)* Weighted Impact Factor (2-yr)©
2016 3.455 3.842 7.295
: : : :
2013 2.508 3.247 5.271
2012 2.553 2.732 3.152

Read explanation to IF and Weighted IF below.
The Review of Diabetic Studies is a member of CrossRef and indexed in DOD and Medline/Pubmed.

The Review of Diabetic Studies (RDS) is a very carefully edited journal, with each paper provided with a scientific and a linguistic expert throughout the entire reviewing and publication process to serve the author and realize the optimal result for the publication of the paper. The reviewing and proof preparation processes are supervised by the Editor, who personally read and carefully edit any paper published before a final language correction is carried out by a professional, English native-speaking linguist.

The Editors attach importance (1) to the way of presentation of the data and information, which should be substantiated, balanced, and novel, and (2) to the selection of topics to address the most burning questions in diabetes research. As the journal and the publisher are totally dedicated to scientific and charitable interests, and are not afflicted with any commercial interests (in contrast to most other journals), the journal's only goal is the progress in science, which is reflected in the carefully editorial work and the huge effort spent by the Editorial Team in order to create excellence and impact-capturing reference in scientific publishing. The Editors wish to increases attention to unresolved issues that are regarded as most important in scientific progress and clinical translation of therapies aimed at both improving diabetes management and an ultimate cure. The RDS Editorial Board comprises a group of leading experts from the different fields of research into diabetes; they are closely colllaborating to identify the most relevant topics and to organize Paper Series Projects addressing these topics.

The RDS supports and encourages research in biomedical diabetes-related science including areas such as endocrinology, immunology, epidemiology, genetics, cell-based research, developmental research, bioengineering and disease management. The journal publishes original manuscripts on laboratory research, clinical and empirical studies, case and conference reports as well as review and theoretical articles and offers an open forum for immediate discussion of recent advancements by letters and comments. Read more.

The journal supports a fast review process. 95% of all reviews are returned to authors within 3-4 weeks after paper submission.
Statistics about paper acceptance and rejection:
The 2015 rejection rate was: 79.8%

Responsibility for the selection of articles in The RDS remains with the Editorial Board. However, the editors do not assume responsibility for the views and statements expressed by the authors.

The RDS is also available online via DOD (Diabetes Open Directory), a database containing information and publications from diabetes-related biomedical research which is currently in its beta stage.


* 2-yr Impact Factor (IF) is a scientific measure to evaluate the performance of a journal based on the citations to articles published in this journal. The 2-yr IF gives the average citation frequency in a journal. It is calculated simply by the number of citations in the reporting year to articles published in the previous two years divided by the number of articles published in these two previous years. The 3-yr impact factor refers to articles published in the previous three years.

© The 2-yr Weighted Impact Factor (WIF) was first created by the SBDR in 2006 as a measure of the "quality" of citations (with "quality" in the sense of the IF approach), appreciating that not only journals, but also citations themselves may have different impacts. This measure is a consequent completion of the IF approach to evaluate journals based on their citations. It takes into account the IF of journals in which the citations took place, thereby providing additional evidence of a journal's performance evaluated on the basis of citations and IFs.

We emphasize that we do not regard IF as the only or best way of evaluating the performance of journals and in particular not the value of articles since the IF of a journal says nothing about the value of an article published in this jounal. Therefore, we regard the today's routine practice to attach the journal's IF to articles published in this journal as fundamentally wrong.

Since the WIF includes the IFs of journals in which the citations took place, a citation in a journal with an IF higher than the average IF over all journals (e.g. 1.852 in 2006) causes an increase in WIF et vice versa. If, for example, the citations took place in journals with an IF 2 times higher (on average) than the average IF over all journals, then the WCF would be 3.704 in 2006. Generally, if the WIF is higher than the simple IF, then the citations took place in journals with IFs higher than the average IF over all journals. Thus, the factor is a measure of the "quality" of citations. The calculation rule is: WIF = (total times of citations x (((times of citations in journal 1 x IF1) + ... + (times of citations in journal n x IFn)) divided by (total times of citations x average IF))) divided by (number of articles published in previous three years).